trending Market Intelligence /marketintelligence/en/news-insights/trending/O1X_tDzSNSg51tLka0dQBg2 content esgSubNav
In This List

US FDA approves Teva Pharmaceutical's pain medication

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits


US FDA approves Teva Pharmaceutical's pain medication

The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.

The treatment is formulated with Teva's proprietary abuse-deterrent technology.